Spartanburg Regional Healthcare System (SRHS) in the US has chosen AccessDx Laboratory as its partner for a pharmacogenomics ...

Pharmacogenetic (PGx) testing involves the analysis of genes known to affect response to medications. The field has been projected as a leading application of personalized or precision medicine ...

The clinical use of pharmacogenetic drugs will require that a sample of a patient's DNA be tested before a drug is prescribed. Although pharmacogenetic tests pose fewer risks than genetic tests ...

A major new study launching in Scotland aims to show how a simple genetic test could help doctors personalise treatments – ...

This study of oncology pharmacogenetic biomarker adoption is primarily limited to the investigation of factors associated with test adoption, not to factors related to the 'end-of-life cycle'.

Application of a Pharmacogenetic Test Adoption Model to Six Oncology Biomarkers Hawazin Faruki; Myla Lai-Goldman Disclosures Personalized Medicine. 2010;7 (4):441-450. 0 ...

Finding the right antidepressant early in treatment may improve response rates, reduce time wasted on trial and error, and reduce the rates of recurrences.

The European direct-to-consumer genetic testing market is expected to reach USD 3.78 billion by 2035, growing from an estimated USD ...

The two most common strategies to test a pharmacogenetic question are the candidate-gene approach and genomewide association study. Given the complex interplay among the many factors that influence a ...

The Business Research Company The Business Research Company's At-Home Genetic Testing Market Analysis 2025 – Insights For Long-Term Investm ...

Dr. Langaee brings over two decades of extensive experience in pharmacogenomics/precision medicine, genetics/ epigenetics, genotyping/sequencing, preemptive clinical pharmacogenomics testing and ...